Persistence of a SARS-CoV-2 T-cell response in patients with long COVID and lung sequelae after COVID-19

1 year after an acute COVID-19 episode, patients with either lung sequelae or long COVID show a stronger SARS-CoV-2-specific T-cell response than fully recovered individuals, suggesting persistent cell stimulation by residual viral reservoirs https://bit.ly/40bPZm7

Detalles Bibliográficos
Autores principales: Cruz, Tamara, Mendoza, Núria, Lledó, Gema M., Perea, Lídia, Albacar, Núria, Agustí, Alvar, Sellares, Jacobo, Sibila, Oriol, Faner, Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204814/
https://www.ncbi.nlm.nih.gov/pubmed/37228290
http://dx.doi.org/10.1183/23120541.00020-2023
Descripción
Sumario:1 year after an acute COVID-19 episode, patients with either lung sequelae or long COVID show a stronger SARS-CoV-2-specific T-cell response than fully recovered individuals, suggesting persistent cell stimulation by residual viral reservoirs https://bit.ly/40bPZm7

Ejemplares similares